Krilogy Financial LLC Bristol Myers Squibb CO Transaction History

Krilogy Financial LLC

$1.35 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$57.89 - $64.73 $291,476 - $325,915	-5,035 Reduced 31.9%	10,748 $623,000
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $828,484 - $919,902	-13,004 Reduced 45.17%	15,783 $1.01 Million
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $1.66 Million - $1.88 Million	-25,197 Reduced 46.67%	28,787 $2 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $2.67 Million - $3.17 Million	39,046 Added 261.39%	53,984 $3.88 Million
Q3 2022 Oct 06, 2022	BUY	$0.13 - $76.84 $48 - $28,661	373 Added 2.56%	14,938 $1.06 Million
Q2 2022 Jul 14, 2022	SELL	$72.62 - $79.98 $52,867 - $58,225	-728 Reduced 4.76%	14,565 $1.12 Million
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $106,913 - $128,199	-1,739 Reduced 10.21%	15,293 $1.12 Million
Q4 2021 Jan 27, 2022	BUY	$53.63 - $62.52 $71,596 - $83,464	1,335 Added 8.5%	17,032 $1.06 Million
Q3 2021 Oct 25, 2021	BUY	$59.17 - $69.31 $440,106 - $515,527	7,438 Added 90.06%	15,697 $929,000
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $27,549 - $30,001	-445 Reduced 5.11%	8,259 $552,000
Q1 2021 Apr 21, 2021	BUY	$59.34 - $66.74 $132,743 - $149,297	2,237 Added 34.59%	8,704 $549,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $288 - $327	5 Added 0.08%	6,467 $401,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $4,938 - $5,473	86 Added 1.35%	6,462 $390,000
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $12,827 - $14,997	234 Added 3.81%	6,376 $374,000
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $41,945 - $60,956	-904 Reduced 12.83%	6,142 $342,000
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $125,633 - $163,877	2,553 Added 56.82%	7,046 $452,000
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $192,165 - $227,840	4,493 New	4,493 $227,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $55,732 - $72,271	-1,143 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $63,082 - $71,151	1,143 New	1,143 $71,000
Q2 2018 Aug 15, 2018	SELL	$50.53 - $62.98 $54,471 - $67,892	-1,078 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $29,730 - $32,413	-496 Reduced 31.51%	1,078 $66,000
Q3 2017 Nov 15, 2017	SELL	$55.23 - $63.74 $8,063 - $9,306	-146 Reduced 8.49%	1,574 $100,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,720	1,720 $96,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.

Account